Chartwell Pharmaceuticals operates four manufacturing and analytical campuses in the New York metropolitan area, developing and producing generic prescription medicines in a broad range of dosage forms. With a leadership team whose members bring more than 20 years of generic-pharmaceutical experience apiece, the company handles work from formulation trials and clinical supplies through commercial production in fully cGMP-compliant facilities. Its U.S.-made portfolio includes more than 1,100 FDA-approved Orange Book listings and products compliant with the Trade Agreements Act and Buy American Act.
Current Good Manufacturing Practice (cGMP)
Compliance program
Trade Agreements Act (TAA) Compliant Production
Compliance program
Buy American Act (BAA) Compliant Products
Compliance program
TAA
Quality certification